Application 209983

Type
ANDA
Sponsor
FRESENIUS KABI USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001POSACONAZOLEPOSACONAZOLESOLUTION;INTRAVENOUS300MG/16.7ML (18MG/ML)NoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
75161ORIG 2023-08-21
72042ORIG2022-09-08